We are live on ! Find out more
Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Portfolio holdings

AUM $30.5B
1-Year Est. Return 29.95%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+29.95%
3 Year Est. Return
+81.25%
5 Year Est. Return
+106.98%
10 Year Est. Return
+342.87%
AUM
$65.7B
AUM Growth
+$24.6M
Cap. Flow
-$1.72B
Cap. Flow %
-2.61%
Top 10 Hldgs %
24.76%
Holding
355
New
32
Increased
93
Reduced
199
Closed
29

Sector Composition

Rank Sector Weight
1 Financials 21.89%
2 Healthcare 20.38%
3 Industrials 14.19%
4 Energy 11.61%
5 Technology 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
1
Philip Morris
PM
$313B
$1.83B 2.79%
18,830,903
-643,357
-3% -$64.4M
JCI icon
2
Johnson Controls International
JCI
$85.8B
$1.75B 2.66%
37,517,268
-22,311
-0.1% -$1.03M
JPM icon
3
JPMorgan Chase
JPM
$931B
$1.71B 2.6%
25,624,180
-4,513,511
-15% -$294M
MDT icon
4
Medtronic
MDT
$112B
$1.64B 2.5%
19,033,448
-2,056,814
-10% -$179M
WFC icon
5
Wells Fargo
WFC
$258B
$1.64B 2.49%
37,011,768
-831,029
-2% -$39.8M
PFE icon
6
Pfizer
PFE
$144B
$1.6B 2.44%
49,819,463
-1,806,713
-3% -$60.4M
VZ icon
7
Verizon
VZ
$201B
$1.6B 2.43%
30,689,076
-1,463,920
-5% -$78.6M
PNC icon
8
PNC Financial Services
PNC
$100B
$1.55B 2.36%
17,222,414
-1,315,177
-7% -$113M
RTX icon
9
RTX Corp
RTX
$294B
$1.49B 2.27%
23,321,200
-789,542
-3% -$52.4M
JNJ icon
10
Johnson & Johnson
JNJ
$646B
$1.46B 2.22%
12,334,416
-876,175
-7% -$106M
QCOM icon
11
Qualcomm
QCOM
$168B
$1.44B 2.19%
21,024,535
-573,470
-3% -$34.9M
APD icon
12
Air Products & Chemicals
APD
$65.5B
$1.41B 2.15%
10,153,231
-1,030,307
-9% -$143M
OXY icon
13
Occidental Petroleum
OXY
$55.8B
$1.4B 2.13%
19,143,706
+101,998
+0.5% +$7.64M
ORCL icon
14
Oracle
ORCL
$340B
$1.4B 2.12%
35,533,375
-694,496
-2% -$28.3M
COP icon
15
ConocoPhillips
COP
$144B
$1.39B 2.12%
32,019,446
+3,485,888
+12% +$145M
BP icon
16
BP
BP
$112B
$1.39B 2.12%
47,002,475
-461,997
-1% -$13.4M
COF icon
17
Capital One
COF
$130B
$1.39B 2.12%
19,345,724
-468,363
-2% -$32.2M
MSFT icon
18
Microsoft
MSFT
$2.91T
$1.34B 2.03%
23,181,015
-1,904,276
-8% -$107M
CAH icon
19
Cardinal Health
CAH
$54.5B
$1.26B 1.92%
16,250,027
+3,729,921
+30% +$301M
BAC icon
20
Bank of America
BAC
$434B
$1.25B 1.9%
79,609,333
-4,452,513
-5% -$66.3M
ESRX
21
DELISTED
Express Scripts Holding Company
ESRX
$1.23B 1.87%
17,407,316
+2,760,945
+19% +$206M
TEVA icon
22
Teva Pharmaceuticals
TEVA
$40.5B
$1.22B 1.86%
26,570,988
+3,870,176
+17% +$202M
MO icon
23
Altria Group
MO
$126B
$1.22B 1.85%
19,238,669
-475,402
-2% -$31.6M
SNY icon
24
Sanofi
SNY
$109B
$1.2B 1.82%
31,320,327
+3,198,048
+11% +$128M
MRK icon
25
Merck
MRK
$323B
$1.16B 1.77%
19,472,922
-8,315,919
-30% -$486M

Similar funds

Barrow, Hanley, Mewhinney & Strauss's Q3 2016 Portfolio in Review

As of Q3 2016, Barrow, Hanley, Mewhinney & Strauss held 355 positions worth $65.7B, up 0.04% from $65.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barrow, Hanley, Mewhinney & Strauss's Q3 2016 filing shows 32 new, 93 increased, 199 reduced and 29 closed positions. Its largest new stake was CVS Health: 9,100,036 shares worth $810M. The largest sale was Intel, an estimated $535M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Barrow, Hanley, Mewhinney & Strauss's largest Q3 2016 buy was CVS Health: 9,100,036 shares worth $810M.
  • Barrow, Hanley, Mewhinney & Strauss added most to Carnival Corporation Ltd in Q3 2016, an estimated $471M increase.
  • Barrow, Hanley, Mewhinney & Strauss's biggest Q3 2016 reduction was Intel, cutting an estimated $535M.
  • Barrow, Hanley, Mewhinney & Strauss fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $336M.
  • Barrow, Hanley, Mewhinney & Strauss's ten largest holdings make up 25% of its $65.7B portfolio in Q3 2016.
  • Barrow, Hanley, Mewhinney & Strauss opened 32 new positions and closed 29 in Q3 2016.
  • Barrow, Hanley, Mewhinney & Strauss's portfolio value rose 0.04% quarter-over-quarter to $65.7B.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q3 2016, filed 10 Nov 2016.